Spark Therapeutics (ONCE) PT Raised to $65 at Stifel
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St set to gain on tech rebound, Middle East in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Alibaba falls on China AI capex report; Citi says selloff is premature
Spark Therapeutics (ONCE) PT Raised to $44 at Wedbush
February 20, 2019 8:27 AM ESTWedbush analyst David Nierengarten raised the price target on Spark Therapeutics (NASDAQ: ONCE) to $44.00 (from $40.00) while maintaining a Neutral rating.
... MoreSpark Therapeutics (ONCE) PT Lowered to $46 at BMO Capital
February 19, 2019 3:38 PM ESTBMO Capital analyst Matthew Luchini lowered the price target on Spark Therapeutics (NASDAQ: ONCE) to $46.00 (from $48.00) while maintaining a Market Perform rating following results.
... MoreSpark Therapeutics (ONCE) PT Lowered to $74 at Barclays
February 19, 2019 11:24 AM ESTBarclays analyst Gena Wang lowered the price target on Spark Therapeutics (NASDAQ: ONCE) to $74.00 (from $77.00) while maintaining a Overweight rating.
... More